A child plays Akili's FDA-approved EndeavorRx video game to treat ADHD.

Ak­ili cuts about 30% of staff in ef­fort to be 'ex­treme­ly lean'

Ak­ili In­ter­ac­tive is ax­ing about a third of its work­force, the com­pa­ny re­vealed last week, while re­or­ga­niz­ing the pipeline around its FDA-cleared video game for at­ten­tion deficit hy­per ac­tiv­i­ty dis­or­der (AD­HD).

CEO Ed­die Mar­tuc­ci said in an in­ter­nal mes­sage to em­ploy­ees on Jan. 12 that Ak­ili’s ex­ec­u­tive team has come to the “nec­es­sary but dif­fi­cult de­ci­sion” to say good­bye to 46 staffers. Those af­fect­ed have been no­ti­fied, and all lay­offs will take place by the end of the quar­ter, ac­cord­ing to an SEC fil­ing.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.